Pennsylvania HB2182 amends the Controlled Substance, Drug, Device and Cosmetic Act to expand the scope of practice for emergency medical services.

HB2182 amends the Controlled Substance, Drug, Device and Cosmetic Act to modify the prehospital practitioner scope of practice for emergency medical services providers. The bill specifically includes the administration of opioid antagonists within their duties. This change aims to enhance the ability of emergency medical services providers to respond to drug overdoses effectively. The bill also confers powers on the courts, the secretary, and the Department of Health, and establishes a newly created Pennsylvania Drug, Device and Cosmetic Board.

Pennsylvania HB2182 amends the Controlled Substance, Drug, Device and Cosmetic Act to expand the scope of practice for emergency medical services.

HB2182 amends the Controlled Substance, Drug, Device and Cosmetic Act to modify the prehospital practitioner scope of practice for emergency medical services providers. The bill specifically includes the administration of opioid antagonists within their duties. This change aims to enhance the ability of emergency medical services providers to respond to drug overdoses effectively. The bill also confers powers on the courts, the secretary, and the Department of Health, and establishes a newly created Pennsylvania Drug, Device and Cosmetic Board.